Signal Transduction and Targeted Therapy
Signal Transduction and Targeted Therapy is an open-access journal published by Springer Nature in the United Kingdom. OpenAlex counts 3,081 works from it, cited 394,034 times; its h-index is 315. Its two-year mean citedness, which is computed the way the impact factor is, is 63.07: a paper it published in the two years before was cited about 63.07 times last year. It published 428 papers in 2025, up 15% from 372 in 2024. Its article processing charge is about US$3,790.
- Publisher
- Springer Nature
- Citations per paper
- 63.07 two-year mean, OpenAlex
- h-index
- 315 i10-index 2,032
- Access
- Open access · in DOAJ
- APC
- US$3,790
- ISSN
- 2059-3635, 2095-9907
- Country
- United Kingdom
- Works published
- 3,081 cited 394,034 times
- Papers in 2025
- 428
- Field
- Medicine
- Website
- Journal home ↗
Signal Transduction and Targeted Therapy year by year
Papers it published each year, and the citations all its papers received that year.
| Year | Papers published | Citations received |
|---|---|---|
| 2026 so far | 509 | 123,200 |
| 2025 | 428 | 111,193 |
| 2024 | 372 | 69,117 |
| 2023 | 467 | 40,092 |
| 2022 | 403 | 25,943 |
| 2021 | 442 | 15,436 |
| 2020 | 301 | 6,204 |
| 2019 | 66 | 1,672 |
What Signal Transduction and Targeted Therapy publishes
Its most frequent research topics, by OpenAlex's topic classification.
- SARS-CoV-2 and COVID-19 ResearchInfectious Diseases · 448 papers
- Cancer Immunotherapy and BiomarkersOncology · 409 papers
- COVID-19 Clinical Research StudiesInfectious Diseases · 276 papers
- Immunotherapy and Immune ResponsesImmunology · 182 papers
- T-cell and B-cell ImmunologyImmunology · 168 papers
Questions about Signal Transduction and Targeted Therapy
What is the impact factor of Signal Transduction and Targeted Therapy?
Clarivate's Journal Impact Factor is licensed and not shown here. OpenAlex's two-year mean citedness, computed the same way from open data, is 63.07 for Signal Transduction and Targeted Therapy: on average, each paper it published in the two years before was cited about 63.07 times in a year.
What is the h-index of Signal Transduction and Targeted Therapy?
315, by OpenAlex's count: 315 of its papers have each been cited at least 315 times. Its i10-index is 2,032.
Is Signal Transduction and Targeted Therapy open access?
Yes. OpenAlex lists Signal Transduction and Targeted Therapy as an open-access journal: its papers are free to read. It is also listed in the Directory of Open Access Journals (DOAJ).
What is the publication fee (APC) of Signal Transduction and Targeted Therapy?
About US$3,790, which is its article processing charge (APC) as listed by OpenAlex. Fees change and waivers exist, so check the journal's own page before you submit.
What is the ISSN of Signal Transduction and Targeted Therapy?
Its linking ISSN is 2059-3635; all its ISSNs: 2059-3635, 2095-9907.
Who publishes Signal Transduction and Targeted Therapy?
Springer Nature, based in the United Kingdom.
How many papers does Signal Transduction and Targeted Therapy publish a year?
428 in 2025, by OpenAlex's count of what it published that year.
What does Signal Transduction and Targeted Therapy publish?
Its most frequent research topics are SARS-CoV-2 and COVID-19 Research, Cancer Immunotherapy and Biomarkers, COVID-19 Clinical Research Studies, in the field of Medicine.
Is Signal Transduction and Targeted Therapy a predatory journal?
Nothing in the scholarly indexes suggests so. Signal Transduction and Targeted Therapy is on OpenAlex's list of core sources, journals with peer review and an editorial board, it has published 3,081 works cited 394,034 times, and it is listed in DOAJ. For a journal you do not know, check the red flags with our predatory journal checker.
Is Signal Transduction and Targeted Therapy indexed in Scopus or Web of Science?
Check the Scopus Sources list and Clarivate's Master Journal List by its ISSN (2059-3635): both are free to search. Our guide on checking journal indexing shows each step.
Journals like Signal Transduction and Targeted Therapy
Other Medicine journals with a similar impact.
Journal data from OpenAlex (CC0), compiled 21 November 2026. Download the whole directory as a CSV file (CC BY 4.0).